Optavise’s Post

Brokers can help employers manage rising healthcare costs with these three strategies. 1. Benefits Advocacy Services that can help employees comparison shop for care. 2. Prescription Drug Management Programs that aim to manage high drug prices. 3. Point Solutions that target specific health needs and high-cost claims Get more details by reading the full article on our blog:

Inflation, increasing prescription drug costs, and chronic clinical workforce shortages are just some of the factors driving up the cost of healthcare in 2024. Cost of care is a major concern for payers and consumers, so it’s no surprise this topic has been in the news frequently. Read our latest #blog to find out what’s trending in the cost of healthcare. #costofcare #visioncare #dentalcare #trendingnow https://lnkd.in/gE78tEht

According to our recent released National Survey of Employer-Sponsored #Health Plans results, prescription drugs rose 8.4% in 2023. We dive into the role prescription drugs are playing in higher #healthcare costs, and how employers can address this in the #FutureofWork. #healthcare

The cost of health benefits per worker increased by 5.3% in 2023, with inflation playing a role in the rising prices. Additionally, prescription drug spending surged by 8.4% during the same period. Find further details in the article.

This is an eye-opening statistic: only about half of employers feel they are effectively managing #healthcare and #prescriptiondrugcosts. What isn't surprising is that high-cost specialty drugs including GLP-1s are a significant contributor. That drug class now accounts for more than $32 billion in annual spend. In 2023, @RxBenefits implemented a new process for GLP-1 prescription reviews that in the first half of 2024 alone saved clients more than $41 million. Our human-led review process includes independent pharmacists who ensure that there is an actual diagnosis for diabetes for any patient prescribed a GLP-1 and we found that in 48% of instances, this was not the case. #highcostdrugs #drugflation

According to our recent released National Survey of Employer-Sponsored #Health Plans results, prescription drugs rose 8.4% in 2023. We dive into the role prescription drugs are playing in higher #healthcare costs, and how employers can address this in the #FutureofWork. #healthcare

According to our recent released National Survey of Employer-Sponsored #Health Plans results, prescription drugs rose 8.4% in 2023. We dive into the role prescription drugs are playing in higher #healthcare costs, and how employers can address this in the #FutureofWork. #healthcare

According to our recent released National Survey of Employer-Sponsored #Health Plans results, prescription drugs rose 8.4% in 2023. We dive into the role prescription drugs are playing in higher #healthcare costs, and how employers can address this in the #FutureofWork. #healthcare

According to our recent released National Survey of Employer-Sponsored #Health Plans results, prescription drugs rose 8.4% in 2023. We dive into the role prescription drugs are playing in higher #healthcare costs, and how employers can address this in the #FutureofWork. #healthcare

#Inflation is only one factor behind this year’s higher cost increases. And while prescription drugs have been the fastest-growing component of #health benefit cost for years, pharmacy benefit cost per employee jumped 8.4% in 2023. Learn more about rising health costs, today. #benefits